Dermatomyositis Recruiting Phase 3 Trials for Abatacept (DB01281)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02971683Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory MyopathyTreatment